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It is becoming widely accepted that polyphenols may act
as strong dietary strategies to combat neurodegenerative
diseases. The articles in this special issue include both
basic scientiﬁc studies along with review articles focused
on demonstrating and understanding the underlying
mechanisms by which puriﬁed polyphenols and/or poly-
phenols containing plant extracts aﬀect cultured brain
cells, animal models of Parkinson’s or Alzheimer’s dis-
eases, and depression.
Alzheimer’s disease is a proteinopathy characterised by
the accumulation of hyperphosphorylated Tau and β-amy-
loid. Autophagy is a physiological process by which aggre-
gated proteins and damaged organelles are eliminated
through lysosomal digestion. Autophagy deﬁciency has
been demonstrated in Alzheimer’s patients. In the research
article “Beneﬁt of Oleuropein Aglycone for Alzheimer’s
Disease by Promoting Autophagy” by J. G. Cordero
et al., the authors demonstrated that oleuropein aglycone,
present in high concentration in extra virgin olive oil, is
capable of inducing autophagy in both in vitro and
in vivo models, and that this leads to an improvement in
cognitive impairment as well as in β-amyloid and Tau
aggregation. The authors propose that supplementation
of diet with extra virgin olive oil may have potential ben-
eﬁts for Alzheimer’s disease patients through the induction
of autophagy by oleuropein aglycone.
The aim of the paper entitled “Mangiferin and Morin
Attenuate Oxidative Stress, Mitochondrial Dysfunction, and
Neurocytotoxicity, Induced by Amyloid Beta Oligomers” by
E. Alberdi et al. was to investigate the neuroprotective eﬀects
of the polyphenols morin and mangiferin against Aβ olig-
omers and their mechanisms of action. The authors found
that these polyphenols mitigated the mitochondrial dys-
function by mechanisms that regulated mitochondrial cal-
cium homeostasis, mitochondrial membrane potential, and
release to cytosol of proapoptotic cytochrome c. Moreover,
morin and mangiferin treatments restored the altered
redox homeostasis of antioxidant enzymes in neurons
treated with oligomeric Aβ. Consequently, these polyphenols
reduced protein oxidation and reestablished bioenergetic
failure in Aβ-treated neurons, contributing to the substantial
reduction of neuronal death.
Chlorogenic acid is a plant polyphenol, which was
found to be a major bioactive constituent of Dendropanax
morbiferus leaves extract. The contribution by S.-Y. Park
et al. entitled “Aqueous Extract of Dendropanax morbiferus
Leaves Eﬀectively Alleviated Neuroinﬂammation and Behav-
ioral Impediments in MPTP-Induced Parkinson’s Mouse
Model” evaluated the underlying molecular mechanism of
the antineuroinﬂammatory activity and the neuroprotec-
tive potential of Dendropanax morbiferus leaves and its
bioactive compound chlorogenic acid in in vitro and
in vivo experimental models of Parkinson’s disease. The
authors demonstrate that prophylactic treatment of Den-
dropanax morbiferus leaves improved the behavioral deﬁ-
cits, inhibited the microglial-mediated neuroinﬂammation,
and protected dopaminergic neuronal loss by restoring
tyrosine hydroxylase levels in brain tissues of the MPTP-
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induced Parkinson’s mouse model. Further, polyphenols that
aﬀect Alzheimer’s and Parkinson’s diseases were also sum-
marised in the systematic review article entitled “Flavonoids
as Therapeutic Agents in Alzheimer’s and Parkinson’s
Diseases: A Systematic Review of Preclinical Evidences” by
R. B. de Andrade Teles et al. The results of their survey
showed that ﬂavonoids, which are the major group of poly-
phenols, are promising candidates for drug development,
but there is a lack of translational research and clinical
evidences which might facilitate their development as drugs.
Polyphenols also received growing interest due to their
potential beneﬁts in treating psychiatric disorders. Their
antioxidant and anti-inﬂammatory activities as well as their
ability to modulate synaptic plasticity contribute to their
mechanism of action. The paper by J. Wang et al. entitled
“An Extract of Artemisia dracunculus L. Promotes Psycho-
logical Resilience in a Mouse Model of Depression” aims at
investigating the potential therapeutic value of this botanical
extract in a model of depression. Artemisia dracunculus L.
(Russian tarragon) extract contains ﬂavonoids, coumarins,
and phenylpropanoid acids. Using a repeated social defeat
stress (RSDS) model of depression, the authors demonstrate
that oral administration of Artemisia dracunculus L. extract
promotes resilience to RSDS-mediated depression-like phe-
notypes. The authors also show that the behavioral improve-
ments are associated with attenuation of stress-mediated
induction of inﬂammatory cytokines in the periphery and
alteration of synaptic plasticity in the nucleus accumbens.
We hope that this special issue would stimulate scientists
from the agricultural, plant sciences, and the medical com-
munities to promote interdisciplinary studies that will lead
to the development of polyphenols as drugs or food supple-
ments for neurodegenerative diseases.
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